← back to search

Jonathan C. Fox

BridgeBio (United States) · US
Area of research
Molecular Biology · Nephrology
Research interest
Research interests include Amyloidosis: Diagnosis, Treatment, Outcomes, Parathyroid Disorders and Treatments, Coagulation, Bradykinin, Polyphosphates, and Angioedema, and Chronic Obstructive Pulmonary Disease (COPD) Research.
h-index
14
citations
2,063
works
46
NIH funding
primary concept
Medicine
email

Recent publications

Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy
Journal of the American College of Cardiology 2025cited by 30position: middledoi
ATTribute-CM Study: Scintigraphic Diagnosis and Long-Term Cardiovascular Outcome Benefits of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Journal of Nuclear Cardiology 2025cited by 0position: middledoi
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Circulation 2024cited by 49position: middledoi
Abstract 4147141: Relationship Between CVH and Survival in the Acoramidis Treated Participants Within ATTRibute-CM
Circulation 2024cited by 0position: middledoi
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Journal of the American College of Cardiology 2019cited by 253position: lastdoi
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis
Journal of Cardiac Failure 2019cited by 103position: middledoi
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
Circulation 2018cited by 818position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kevin Alexander · Palo Alto University4 papers (2024–2025)Jean‐François Tamby · Medical University of South Carolina4 papers (2024–2025)Nitasha Sarswat · Brigham and Women's Hospital3 papers (2024–2025)Mathew S. Maurer · Columbia University Irving Medical Center3 papers (2024–2025)Amrut V. Ambardekar · University of Colorado Colorado Springs3 papers (2024–2025)Ahmad Masri · The University of Texas Southwestern Medical Center3 papers (2024–2025)Daniel P. Judge · Brigham and Women's Hospital3 papers (2019–2025)Francesco Cappelli · Azienda Sanitaria Universitaria Integrata di Trieste3 papers (2024–2025)Uma Sinha · BridgeBio (United States)3 papers (2019–2025)Prem Soman · Oregon Health & Science University3 papers (2024–2025)José Nativi-Nicolau · Mayo Clinic in Arizona3 papers (2019–2024)Keyur B. Shah · University College London2 papers (2024–2025)Steen Hvitfeldt Poulsen · Aarhus University Hospital2 papers (2024–2025)Julian D. Gillmore · Alnylam Pharmaceuticals (United States)2 papers (2024–2025)Matthew J. Maurer · Toyota Motor Corporation (Switzerland)2 papers (2019–2019)Pablo García‐Pavía · Hospital La Paz Institute for Health Research2 papers (2024–2025)Daniel Jacoby · Yale University2 papers (2018–2019)Laura Obici · University of Pavia2 papers (2024–2025)Martha Grogan · Mayo Clinic2 papers (2019–2024) · 1 papers (2025–2025)